Plasma interferon predicts pulmonary hypertension severity and outcome
These findings suggest that plasma IFN-α may serve as a valuable biomarker for both predicting PH risk and assessing prognosis.
Authors
- Xiaohuan Xia (ORCID: https://orcid.org/0000-0002-0287-6319)
- Jie Zhu (ORCID: https://orcid.org/0000-0001-9386-9052)
- Shenli Jia (ORCID: https://orcid.org/0000-0003-2782-2234)
- Yun Li (ORCID: https://orcid.org/0000-0002-8101-0192)
- Jinling Li (ORCID: https://orcid.org/0000-0002-0187-9112)
- Fei Li (ORCID: https://orcid.org/0000-0002-0532-9054)
- Zhanping Liang
- Yuyan Liu
Institutions
- Tongji University (CN)
- Shanghai Pulmonary Hospital (CN)
- Shanghai East Hospital (CN)
- Shanghai Tenth People's Hospital (CN)
- Tongji Hospital (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-11-05
- DOI
- https://doi.org/10.3389/fcvm.2025.1634764
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Tongji University